{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:42Z","timestamp":1792682802984,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hereditary spastic paraplegia (HSP) refers to a heterogeneous group of genetic disorders with more than 90 causative genes. Clinically, HSP is classified into pure and complicated forms. Pure forms are characterized primarily by lower-limb spasticity and weakness, whereas complicated forms include additional neurological or non-neurological symptoms alongside spasticity and weakness. We aimed to characterize the clinical and genetic landscapes of HSP in an Iranian cohort. Whole-exome sequencing (WES) was performed on 103 unrelated clinically suspected HSP probands. Multiple ligation-dependent probe amplification (MLPA) was performed to validate identified copy number variants (CNVs) in two probands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      71 pathogenic\/likely pathogenic and VUS variants were identified in 81 probands; total genetically solved probands: 78.6%. Among these solved cases, 64 probands harbored variants in known HSP genes, 14 had variants in other neuromuscular\/neurodegenerative-related genes, and the remaining 3 probands carried variants in four novel candidate genes including\n                      <jats:italic>NMNAT1, SEMA3A, KCNJ14<\/jats:italic>\n                      , and\n                      <jats:italic>EMP3<\/jats:italic>\n                      . Among all 71 identified genomic variants, two were CNVs and one was a trinucleotide repeat expansion. Taken together, these variants were located in 37 genes; 21 of these genes have been previously implicated in HSP, and four common HSP subtypes (SPG11, SPG4, SPG7, and SPG15) accounted for ~40% of our cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates significant clinical and genetic heterogeneity of HSP within our cohort. In addition to variants in 21 known HSP-related genes, we identified variants in 14 genes related to other neurological disorders -highlighting shared biological pathways- as well as variants in four novel candidate genes. Notably, a genetic diagnosis could not be established in 22 probands, underscoring that additional, as yet unidentified genes likely contribute to HSP pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04373-8","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:27:27Z","timestamp":1778596047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding the genetic and clinical landscapes of hereditary spastic paraplegia (HSP): a cohort study of 103 families"],"prefix":"10.1186","volume":"21","author":[{"given":"Atefeh","family":"Davarzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moez","family":"Ravanbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Najmabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Fatehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Firoozfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Zemorshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Habibi-Kavashkohie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-2475","authenticated-orcid":false,"given":"Afagh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"4373_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-323-98817-9.00022-3","volume":"196","author":"JK Fink","year":"2023","unstructured":"Fink JK. The hereditary spastic paraplegias. Handb Clin Neurol. 2023;196:59\u201388.","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"4373_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","volume":"18","author":"S Shribman","year":"2019","unstructured":"Shribman S, Reid E, Crosby AH, Houlden H, Warner TT. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol. 2019;18(12):1136\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(19)30235-2.","journal-title":"The Lancet Neurol"},{"key":"4373_CR3","doi-asserted-by":"publisher","unstructured":"Fink JK. Advances in the hereditary spastic paraplegias. Exp Neurol. 2003;184 Suppl 1:S106\u2013110. https:\/\/doi.org\/10.1016\/j.expneurol.2003.08.005.","DOI":"10.1016\/j.expneurol.2003.08.005"},{"issue":"8334","key":"4373_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"321","author":"AE Harding","year":"1983","unstructured":"Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;321(8334):1151\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(83)92879-9.","journal-title":"Lancet"},{"key":"4373_CR5","doi-asserted-by":"publisher","first-page":"635032","DOI":"10.3389\/fneur.2021.635032","volume":"12","author":"N De Beukelaer","year":"2021","unstructured":"De Beukelaer N, Bar-On L, Hanssen B, Peeters N, Prinsen S, Ortibus E, et al. Muscle characteristics in pediatric hereditary spastic paraplegia vs. bilateral spastic cerebral palsy: an exploratory study. Front Neurol. 2021;12:635032. https:\/\/doi.org\/10.3389\/fneur.2021.635032.","journal-title":"Front Neurol"},{"key":"4373_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/B978-0-444-64076-5.00041-7","volume":"148","author":"C Blackstone","year":"2018","unstructured":"Blackstone C. Hereditary spastic paraplegia. Handb Clin Neurol. 2018;148:633\u201352.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"4373_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","volume":"16","author":"de Souza PVS","year":"2017","unstructured":"de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum. 2017;16(2):525\u201351. https:\/\/doi.org\/10.1007\/s12311-016-0803-z.","journal-title":"Cerebellum"},{"issue":"7","key":"4373_CR8","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00415-014-7598-y","volume":"262","author":"A Hensiek","year":"2015","unstructured":"Hensiek A, Kirker S, Reid E. Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing. J Neurol. 2015;262(7):1601\u201312. https:\/\/doi.org\/10.1007\/s00415-014-7598-y.","journal-title":"J Neurol"},{"issue":"4","key":"4373_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11910-021-01099-x","volume":"21","author":"L Saputra","year":"2021","unstructured":"Saputra L, Kumar KR. Challenges and controversies in the genetic diagnosis of hereditary spastic paraplegia. Curr Neurol Neurosci Rep. 2021;21(4):15. https:\/\/doi.org\/10.1007\/s11910-021-01099-x.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"4373_CR10","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/ijms23031697","volume":"23","author":"A Meyyazhagan","year":"2022","unstructured":"Meyyazhagan A, Orlacchio A. Hereditary spastic paraplegia: an update. Int J Mol Sci. 2022;23(3):1697. https:\/\/doi.org\/10.3390\/ijms23031697.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4373_CR11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/mds.28528","volume":"36","author":"MA Estiar","year":"2021","unstructured":"Estiar MA, Yu E, Haj Salem I, Ross JP, Mufti K, Ak\u00e7imen F, et al. Evidence for non-Mendelian inheritance in spastic paraplegia 7. Mov Disord. 2021;36(7):1664\u201375. https:\/\/doi.org\/10.1002\/mds.28528.","journal-title":"Mov Disord"},{"issue":"1","key":"4373_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12311-024-01758-y","volume":"24","author":"E Fratto","year":"2024","unstructured":"Fratto E, Morelli M, Buonocore J, Quattrone A, Procopio R, Gagliardi M, et al. Hereditary spastic paraplegia associated with ultra-rare variant enrichment encompassing the SYNE1, CAPN1 and PGAP1 genes. Cerebellum. 2024;24(1):3. https:\/\/doi.org\/10.1007\/s12311-024-01758-y.","journal-title":"Cerebellum"},{"issue":"6","key":"4373_CR13","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00415-019-09633-1","volume":"268","author":"M Erfanian Omidvar","year":"2021","unstructured":"Erfanian Omidvar M, Torkamandi S, Rezaei S, Alipoor B, Omrani MD, Darvish H, et al. Genotype\u2013phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients. J Neurol. 2021;268(6):2065\u201382. https:\/\/doi.org\/10.1007\/s00415-019-09633-1.","journal-title":"J Neurol"},{"issue":"6","key":"4373_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00439-015-1536-7","volume":"134","author":"C Tesson","year":"2015","unstructured":"Tesson C, Koht J, Stevanin G. Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. Hum Genet. 2015;134(6):511\u201338. https:\/\/doi.org\/10.1007\/s00439-015-1536-7.","journal-title":"Hum Genet"},{"issue":"1","key":"4373_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12311-018-0969-7","volume":"18","author":"C Kang","year":"2019","unstructured":"Kang C, Liang C, Ahmad KE, Gu Y, Siow SF, Colebatch JG, et al. High degree of genetic heterogeneity for hereditary cerebellar ataxias in Australia. Cerebellum. 2019;18(1):137\u201346. https:\/\/doi.org\/10.1007\/s12311-018-0969-7.","journal-title":"Cerebellum"},{"issue":"12","key":"4373_CR16","doi-asserted-by":"publisher","first-page":"103605","DOI":"10.1016\/j.ejmg.2018.12.010","volume":"62","author":"A Shetty","year":"2019","unstructured":"Shetty A, Gan-Or Z, Ashtiani S, Ruskey JA, van de Warrenburg B, Wassenberg T, et al. CAPN1 mutations: expanding the CAPN1-related phenotype: from hereditary spastic paraparesis to spastic ataxia. Eur J Med Genet. 2019;62(12):103605. https:\/\/doi.org\/10.1016\/j.ejmg.2018.12.010.","journal-title":"Eur J Med Genet"},{"issue":"7","key":"4373_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/jmedgenet-2020-107007","volume":"58","author":"F Nicita","year":"2021","unstructured":"Nicita F, Ginevrino M, Travaglini L, D\u2019Arrigo S, Zorzi G, Borgatti R, et al. Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet. 2021;58(7):475\u201383. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107007.","journal-title":"J Med Genet"},{"issue":"1","key":"4373_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-8-41","volume":"8","author":"M Synofzik","year":"2013","unstructured":"Synofzik M, Soehn AS, Gburek-Augustat J, Schicks J, Karle KN, Schule R, et al. Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum. Orphanet J Rare Dis. 2013;8(1):41. https:\/\/doi.org\/10.1186\/1750-1172-8-41.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"4373_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ana.25220","volume":"83","author":"E Seong","year":"2018","unstructured":"Seong E, Insolera R, Dulovic M, Kamsteeg EJ, Trinh J, Bruggemann N, et al. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. Ann Neurol. 2018;83(6):1075\u201388. https:\/\/doi.org\/10.1002\/ana.25220.","journal-title":"Ann Neurol"},{"issue":"1","key":"4373_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00415-016-8301-2","volume":"264","author":"T Musacchio","year":"2017","unstructured":"Musacchio T, Zaum AK, \u00dc\u00e7eyler N, Sommer C, Pfeifroth N, Reiners K, et al. ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. J Neurol. 2017;264(1):11\u201320. https:\/\/doi.org\/10.1007\/s00415-016-8301-2.","journal-title":"J Neurol"},{"issue":"1","key":"4373_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/brain\/awv320","volume":"139","author":"C Montecchiani","year":"2016","unstructured":"Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, et al. ALS5\/SPG11\/ KIAA1840 mutations cause autosomal recessive axonal Charcot\u2013Marie\u2013Tooth disease. Brain. 2016;139(1):73\u201385. https:\/\/doi.org\/10.1093\/brain\/awv320.","journal-title":"Brain"},{"issue":"11","key":"4373_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/jnnp-2013-305049","volume":"84","author":"M Gonzalez","year":"2013","unstructured":"Gonzalez M, McLaughlin H, Houlden H, Guo M, Yo-Tsen L, Hadjivassilious M, et al. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry. 2013;84(11):1247\u201349. https:\/\/doi.org\/10.1136\/jnnp-2013-305049.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"4373_CR23","doi-asserted-by":"publisher","unstructured":"Schottmann G, Seelow D, Seifert F, Morales-Gonzalez S, Gill E, von Au K, et al. Recessive REEP1 mutation is associated with congenital axonal neuropathy and diaphragmatic palsy. Neurol Genet. 2015;1(4):e32. https:\/\/doi.org\/10.1212\/NXG.0000000000000032.","DOI":"10.1212\/NXG.0000000000000032"},{"issue":"11","key":"4373_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/jnnp-2020-323719","volume":"91","author":"A Cortese","year":"2020","unstructured":"Cortese A, Callegari I, Curr\u00f2 R, Vegezzi E, Colnaghi S, Versino M, et al. Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic. J Neurol Neurosurg Psychiatry. 2020;91(11):1237\u201338. https:\/\/doi.org\/10.1136\/jnnp-2020-323719.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"issue":"5","key":"4373_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41431-018-0107-5","volume":"26","author":"C Tunca","year":"2018","unstructured":"Tunca C, Akcimen F, Coskun C, Gundogdu-Eken A, Kocoglu C, Cevik B, et al. ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur J Hum Genet. 2018;26(5):745\u201348. https:\/\/doi.org\/10.1038\/s41431-018-0107-5.","journal-title":"Eur J Hum Genet"},{"key":"4373_CR26","doi-asserted-by":"publisher","unstructured":"Amador MDM, Muratet F, Teyssou E, Banneau G, Danel-Brunaud V, Allart E, et al. Spastic paraplegia due to recessive or dominant mutations in ERLIN2 can convert to ALS. Neurol Genet. 2019;5(6):e374. https:\/\/doi.org\/10.1212\/NXG.0000000000000374.","DOI":"10.1212\/NXG.0000000000000374"},{"key":"4373_CR27","doi-asserted-by":"publisher","unstructured":"Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, et al. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging. 2012;33(4):.e839.5\u201399. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.11.012.","DOI":"10.1016\/j.neurobiolaging.2011.11.012"},{"issue":"10","key":"4373_CR28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/mds.27491","volume":"33","author":"I Faber","year":"2018","unstructured":"Faber I, Martinez ARM, Martins CR Jr, Maia ML, Souza JP, Lourenco CM, et al. SPG11-related parkinsonism: clinical profile, molecular imaging and l-dopa response. Mov Disord. 2018;33(10):1650\u201356. https:\/\/doi.org\/10.1002\/mds.27491.","journal-title":"Mov Disord"},{"issue":"10","key":"4373_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Gr\u00fcndemann J, Stiller B, Hampshire D, Cid LP, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006;38(10):1184\u201391. https:\/\/doi.org\/10.1038\/ng1884.","journal-title":"Nat Genet"},{"issue":"6701","key":"4373_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson\u2019s disease. Nature. 1998;395(6701):451\u201352. https:\/\/doi.org\/10.1038\/26652.","journal-title":"Nature"},{"issue":"10","key":"4373_CR31","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/antiox9101020","volume":"9","author":"I Hinarejos","year":"2020","unstructured":"Hinarejos I, Machuca-Arellano C, Sancho P, Espin\u00f3s C. Mitochondrial dysfunction, oxidative stress and neuroinflammation in neurodegeneration with brain iron accumulation (NBIA). Antioxid (Basel). 2020;9(10):1020. https:\/\/doi.org\/10.3390\/antiox9101020.","journal-title":"Antioxid (Basel)"},{"issue":"3","key":"4373_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ejhg.2016.168","volume":"25","author":"van de Warrenburg Bp","year":"2017","unstructured":"van de Warrenburg Bp, Schouten MI, de Bot St, Vermeer S, Meijer R, Pennings M, et al. Erratum: clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene\u2013disease associations and unanticipated rare disorders. Eur J Hum Genet. 2017;25(3):393. https:\/\/doi.org\/10.1038\/ejhg.2016.168.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"4373_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/brainsci11020246","volume":"11","author":"V Riso","year":"2021","unstructured":"Riso V, Rossi S, Nicoletti TF, Tessa A, Travaglini L, Zanni G, et al. Application of a clinical workflow may lead to increased diagnostic precision in hereditary spastic paraplegias and cerebellar ataxias: a single center experience. Brain Sci. 2021;11(2):246. https:\/\/doi.org\/10.3390\/brainsci11020246.","journal-title":"Brain Sci"},{"issue":"11","key":"4373_CR34","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ejhg.2017.124","volume":"25","author":"S Morais","year":"2017","unstructured":"Morais S, Raymond L, Mairey M, Coutinho P, Brand\u00e3o E, Ribeiro P, et al. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet. 2017;25(11):1217\u201328. https:\/\/doi.org\/10.1038\/ejhg.2017.124.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4373_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.24611","volume":"79","author":"R Sch\u00fcle","year":"2016","unstructured":"Sch\u00fcle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79(4):646\u201358. https:\/\/doi.org\/10.1002\/ana.24611.","journal-title":"Ann Neurol"},{"issue":"5","key":"4373_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cge.14280","volume":"103","author":"H Fussiger","year":"2023","unstructured":"Fussiger H, Pereira B, Padilha JPD, Donis KC, Siebert M, Brusius-Facchin AC, et al. Copy number variations in SPAST and ATL1 are rare among Brazilians. Clin Genet. 2023;103(5):580\u201384. https:\/\/doi.org\/10.1111\/cge.14280.","journal-title":"Clin Genet"},{"issue":"2","key":"4373_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10048-014-0429-6","volume":"16","author":"E Lopez","year":"2015","unstructured":"Lopez E, Casasnovas C, Gimenez J, Matilla-Duenas A, Sanchez I, Volpini V. Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia. Neurogenetics. 2015;16(2):97\u2013105. https:\/\/doi.org\/10.1007\/s10048-014-0429-6.","journal-title":"Neurogenetics"},{"issue":"7","key":"4373_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/humu.23000","volume":"37","author":"S Gunther","year":"2016","unstructured":"Gunther S, Elert-Dobkowska E, Soehn AS, Hinreiner S, Yoon G, Heller R, et al. High frequency of pathogenic rearrangements in SPG11 and extensive contribution of mutational hotspots and founder alleles. Hum Mutat. 2016;37(7):703\u201309. https:\/\/doi.org\/10.1002\/humu.23000.","journal-title":"Hum Mutat"},{"issue":"4","key":"4373_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/mds.29728","volume":"39","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zheng H, Zhu Z, Yao L, Tian W, Cao L. Clinical and genetic spectrum in a large cohort of hereditary spastic paraplegia. Mov Disord. 2024;39(4):651\u201362. https:\/\/doi.org\/10.1002\/mds.29728.","journal-title":"Mov Disord"},{"issue":"12","key":"4373_CR40","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1007\/s10072-023-06932-4","volume":"44","author":"N Hashemi","year":"2023","unstructured":"Hashemi N, Abadi RNS, Alavi A, Rohani M, Ghasemi A, Tavasoli AR. The first reports of FA2H-associated neurodegeneration from two unrelated Iranian families. Neurol. Sci. 2023;44(12):4359\u201362. https:\/\/doi.org\/10.1007\/s10072-023-06932-4.","journal-title":"Neurol. Sci"},{"issue":"2","key":"4373_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/01677063.2021.1895146","volume":"35","author":"M Pashaei","year":"2021","unstructured":"Pashaei M, Davarzani A, Hajati R, Zamani B, Nafissi S, Larti F, et al. Description of clinical features and genetic analysis of one ultra-rare (SPG64) and two common forms (SPG5A and SPG15) of hereditary spastic paraplegia families. J Neurogenet. 2021;35(2):84\u201394. https:\/\/doi.org\/10.1080\/01677063.2021.1895146.","journal-title":"J Neurogenet"},{"issue":"6","key":"4373_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000531507","volume":"14","author":"A Ghasemi","year":"2023","unstructured":"Ghasemi A, Sadr Z, Babanejad M, Rohani M, Alavi A. Copy number variations in hereditary spastic paraplegia-related genes: evaluation of an Iranian hereditary spastic paraplegia cohort and literature review. Mol Syndromol. 2023;14(6):477\u201384. https:\/\/doi.org\/10.1159\/000531507.","journal-title":"Mol Syndromol"},{"issue":"10","key":"4373_CR43","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/00207454.2020.1763344","volume":"131","author":"MM Rahimi Bidgoli","year":"2021","unstructured":"Rahimi Bidgoli MM, Javanparast L, Rohani M, Najmabadi H, Zamani B, Alavi A. CAPN1 and hereditary spastic paraplegia: a novel variant in an Iranian family and overview of the genotype-phenotype correlation. Int J Neurosci. 2021;131(10):962\u201374. https:\/\/doi.org\/10.1080\/00207454.2020.1763344.","journal-title":"Int J Neurosci"},{"issue":"2","key":"4373_CR44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ajmg.a.61983","volume":"185","author":"SS Hashemi","year":"2021","unstructured":"Hashemi SS, Zare-Abdollahi D, Bakhshandeh MK, Vafaee A, Abolhasani S, Inanloo Rahatloo K, et al. Clinical spectrum in multiple families with primary COQ 10 deficiency. Am J Med Genet Pt A. 2021;185(2):440\u201352. https:\/\/doi.org\/10.1002\/ajmg.a.61983.","journal-title":"Am J Med Genet Pt A"},{"issue":"11","key":"4373_CR45","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/00207454.2023.2260091","volume":"134","author":"Z Sadr","year":"2024","unstructured":"Sadr Z, Rohani M, Jamali P, Alavi A. A case report of concurrent occurrence of two inherited axonopathies within a family: the benefit of whole-exome sequencing. Int J Neurosci. 2024;134(11):1282\u201387. https:\/\/doi.org\/10.1080\/00207454.2023.2260091.","journal-title":"Int J Neurosci"},{"issue":"1","key":"4373_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10048-024-00789-1","volume":"26","author":"Z Sadr","year":"2024","unstructured":"Sadr Z, Ghasemi A, Rohani M, Khorram Khorshid HR, Habibi-Kavashkohie MR, Mohammadi Y, et al. Three Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69. Neurogenetics. 2024;26(1):12. https:\/\/doi.org\/10.1007\/s10048-024-00789-1.","journal-title":"Neurogenetics"},{"issue":"7","key":"4373_CR47","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s10072-023-06707-x","volume":"44","author":"Z Sadr","year":"2023","unstructured":"Sadr Z, Zare-Abdollahi D, Rohani M, Alavi A. A founder mutation in COQ7, p.(Leu111Pro), causes pure hereditary spastic paraplegia (HSP) in the Iranian population. Neurol. Sci. 2023;44(7):2599\u2013602. https:\/\/doi.org\/10.1007\/s10072-023-06707-x.","journal-title":"Neurol. Sci"},{"issue":"6","key":"4373_CR48","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s10072-021-05815-w","volume":"43","author":"A Davarzani","year":"2022","unstructured":"Davarzani A, Shahrokhi A, Hashemi SS, Ghasemi A, Habibi Kavashkohei MR, Farboodi N, et al. The second family affected with a PRDM8-related disease. Neurol. Sci. 2022;43(6):3847\u201355. https:\/\/doi.org\/10.1007\/s10072-021-05815-w.","journal-title":"Neurol. Sci"},{"issue":"5","key":"4373_CR49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1017\/cjn.2021.188","volume":"49","author":"SS Hashemi","year":"2022","unstructured":"Hashemi SS, Hajati R, Davarzani A, Rohani M, DanaeeFard F, Rahimi Bidgoli MM, et al. Anticipation can Be more common in hereditary spastic paraplegia with SPAST mutations than it appears. Can J Neurol Sci. 2022;49(5):651\u201361. https:\/\/doi.org\/10.1017\/cjn.2021.188.","journal-title":"Can J Neurol Sci"},{"key":"4373_CR50","doi-asserted-by":"publisher","unstructured":"Khani M, Shamshiri H, Fatehi F, Rohani M, Haghi Ashtiani B, Akhoundi FH, et al. Description of combined ARHSP\/JALS phenotype in some patients with SPG11 mutations. Molec Gen Gen Med. 2020;8(7):e 1240. https:\/\/doi.org\/10.1002\/mgg3.1240.","DOI":"10.1002\/mgg3.1240"},{"key":"4373_CR51","doi-asserted-by":"publisher","unstructured":"Habibi-Kavashkohie MR, Danaeefard F, Rohani M, Alavi A. Expanding the phenotypic spectrum of RNASEH2B mutations: a new case of pure hereditary spastic paraplegia and a systematic review. CJN. 2026;104\u201314. https:\/\/doi.org\/10.18502\/cjn.v24i2.20683.","DOI":"10.18502\/cjn.v24i2.20683"},{"key":"4373_CR52","doi-asserted-by":"publisher","first-page":"149463","DOI":"10.1016\/j.gene.2025.149463","volume":"956","author":"M Ravanbod","year":"2025","unstructured":"Ravanbod M, Mohammadi M, Soleimani P, Zemorshidi F, Nafissi S, Alavi A. Clinical and molecular assessment of a spastic ataxia 4 (SPAX4) patient with a novel variant in the MTPAP gene, and a systematic review. Gene. 2025;956:149463. https:\/\/doi.org\/10.1016\/j.gene.2025.149463.","journal-title":"Gene"},{"issue":"5","key":"4373_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000529678","volume":"14","author":"A Ghasemi","year":"2023","unstructured":"Ghasemi A, Tavasoli AR, Khojasteh M, Rohani M, Alavi A. Description of phenotypic heterogeneity in a GJC2-related family and Literature review. Mol Syndromol. 2023;14(5):405\u201315. https:\/\/doi.org\/10.1159\/000529678.","journal-title":"Mol Syndromol"},{"issue":"4","key":"4373_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nmd.2023.02.001","volume":"33","author":"Z Sadr","year":"2023","unstructured":"Sadr Z, Ghasemi A, Rohani M, Alavi A. NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants. Neuromuscul Disord. 2023;33(4):295\u2013301. https:\/\/doi.org\/10.1016\/j.nmd.2023.02.001.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"4373_CR55","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","volume":"67","author":"R Sch\u00fcle","year":"2006","unstructured":"Sch\u00fcle R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, et al. The spastic paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology. 2006;67(3):430\u201334. https:\/\/doi.org\/10.1212\/01.wnl.0000228242.53336.90.","journal-title":"Neurology"},{"issue":"5","key":"4373_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"4373_CR57","doi-asserted-by":"publisher","unstructured":"Salari M, Hojjatipour F, Etemadifar M, Soleimani S. Review of the genetic spectrum of hereditary spastic paraplegias in the Middle East and North Africa regions. Neurol Genet. 2025;11(2):e200250. https:\/\/doi.org\/10.1212\/NXG.0000000000200250.","DOI":"10.1212\/NXG.0000000000200250"},{"issue":"6\u20137","key":"4373_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurol.2015.02.017","volume":"171","author":"S Klebe","year":"2015","unstructured":"Klebe S, Stevanin G, Depienne C. Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Revue Neurologique. 2015;171(6\u20137):505\u201330. https:\/\/doi.org\/10.1016\/j.neurol.2015.02.017.","journal-title":"Revue Neurologique"},{"key":"4373_CR59","doi-asserted-by":"publisher","unstructured":"Kang Y-R, Nam T-S, Kim J-M, Kang KW, Choi S-M, Lee S-H, et al. Clinical analysis in patients with SPG11 hereditary spastic paraplegia. Front Neurol. 2023;14:- 2023. https:\/\/doi.org\/10.3389\/fneur.2023.1198728.","DOI":"10.3389\/fneur.2023.1198728"},{"issue":"1","key":"4373_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12883-022-02595-4","volume":"22","author":"G Vander Stichele","year":"2022","unstructured":"Vander Stichele G, Durr A, Yoon G, Sch\u00fcle R, Blackstone C, Esposito G, et al. An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15. BMC Neurol. 2022;22(1):115. https:\/\/doi.org\/10.1186\/s12883-022-02595-4.","journal-title":"BMC Neurol"},{"key":"4373_CR61","doi-asserted-by":"publisher","unstructured":"Chrestian N, Dupr\u00e9 N, Gan-Or Z, Szuto A, Chen S, Venkitachalam A, et al. Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet. 2017;3(1):e122. https:\/\/doi.org\/10.1212\/NXG.0000000000000122.","DOI":"10.1212\/NXG.0000000000000122"},{"issue":"2","key":"4373_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000177033","volume":"32","author":"M Braschinsky","year":"2009","unstructured":"Braschinsky M, Luus SM, Gross-Paju K, Haldre S. The prevalence of hereditary spastic paraplegia and the occurrence of SPG4 mutations in Estonia. Neuroepidemiology. 2009;32(2):89\u201393. https:\/\/doi.org\/10.1159\/000177033.","journal-title":"Neuroepidemiology"},{"issue":"4","key":"4373_CR63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamaneurol.2013.1956","volume":"70","author":"JL Loureiro","year":"2013","unstructured":"Loureiro JL, Brand\u00e3o E, Ruano L, Brand\u00e3o AF, Lopes AM, Thieleke-Matos C, et al. Autosomal dominant spastic paraplegias: a review of 89 families resulting from a Portuguese survey. JAMA Neurol. 2013;70(4):481\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1956.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4373_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S0317167100006053","volume":"34","author":"PL Reddy","year":"2007","unstructured":"Reddy PL, Seltzer WK, Grewal RP. Possible anticipation in hereditary spastic paraplegia type 4 (SPG4). Can J Neurol Sci. 2007;34(2):208\u201310. https:\/\/doi.org\/10.1017\/S0317167100006053.","journal-title":"Can J Neurol Sci"},{"key":"4373_CR65","doi-asserted-by":"publisher","unstructured":"Lallemant-Dudek P, Guillaud-Bataille M, Hentzen C, Joussain C, Pichon B, Robain G, et al. Hereditary spastic paraplegias: when to expect bladder dysfunction a genetic and urodynamic study. Euro J Neurol. 2025;32(1):e70003. https:\/\/doi.org\/10.1111\/ene.70003.","DOI":"10.1111\/ene.70003"},{"issue":"3","key":"4373_CR66","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/brain\/awm293","volume":"131","author":"G Stevanin","year":"2008","unstructured":"Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131(3):772\u201384. https:\/\/doi.org\/10.1093\/brain\/awm293.","journal-title":"Brain"},{"key":"4373_CR67","doi-asserted-by":"publisher","unstructured":"Shi Y, Wang A, Chen B, Wang X, Niu S, Li W, et al. Clinical features and genetic spectrum of patients with clinically suspected hereditary progressive spastic paraplegia. Front Neurol. 2022;13:- 2022. https:\/\/doi.org\/10.3389\/fneur.2022.872927.","DOI":"10.3389\/fneur.2022.872927"},{"issue":"1","key":"4373_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3174\/ajnr.A5935","volume":"40","author":"B Pascual","year":"2019","unstructured":"Pascual B, de Bot ST, Daniels MR, Fran\u00e7a MC, Toro C, Riverol M, et al. \u201cEars of the lynx\u201d MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia. AJNR Am J Neuroradiol. 2019;40(1):199. https:\/\/doi.org\/10.3174\/ajnr.A5935.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"4373_CR69","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/brain\/awz102","volume":"142","author":"TW Rattay","year":"2019","unstructured":"Rattay TW, Lindig T, Baets J, Smets K, Deconinck T, S\u00f6hn AS, et al. FAHN\/SPG35: a narrow phenotypic spectrum across disease classifications. Brain. 2019;142(6):1561\u201372. https:\/\/doi.org\/10.1093\/brain\/awz102.","journal-title":"Brain"},{"issue":"10","key":"4373_CR70","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/humu.22378","volume":"34","author":"G Landour\u00e9","year":"2013","unstructured":"Landour\u00e9 G, Zhu PP, Louren\u00e7o CM, Johnson JO, Toro C, Bricceno KV, et al. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat. 2013;34(10):1357\u201360. https:\/\/doi.org\/10.1002\/humu.22378.","journal-title":"Hum Mutat"},{"issue":"4","key":"4373_CR71","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/acn3.52037","volume":"11","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Xiong Y, Wang L, Zhu M, Tan D, Hong D. Homozygous variant in COQ7 causes autosomal recessive hereditary spastic paraplegia. Ann Clin Transl Neurol. 2024;11(4):1067\u201374. https:\/\/doi.org\/10.1002\/acn3.52037.","journal-title":"Ann. Clin. Transl. Neurol"},{"issue":"1","key":"4373_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cge.13955","volume":"100","author":"P Varghaei","year":"2021","unstructured":"Varghaei P, Yoon G, Estiar MA, Veyron S, Leveille E, Dupr\u00e9 N, et al. GCH1 mutations in hereditary spastic paraplegia. Clin Genet. 2021;100(1):51\u201358. https:\/\/doi.org\/10.1111\/cge.13955.","journal-title":"Clin Genet"},{"key":"4373_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.03.019","volume":"74","author":"T Wassenberg","year":"2020","unstructured":"Wassenberg T, Schouten MI, Helmich RC, Willemsen M, Kamsteeg EJ, van de Warrenburg BPC. Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset. Parkinsonism & Relat Disord. 2020;74:12\u201315. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.03.019.","journal-title":"Parkinsonism & Relat Disord"},{"issue":"6","key":"4373_CR74","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0038-1672174","volume":"49","author":"C Spagnoli","year":"2018","unstructured":"Spagnoli C, Frattini D, Salerno GG, Fusco C. RNASEH2B pathogenic gene variant in uncomplicated hereditary spastic paraplegia: report of a new patient. Neuropediatrics. 2018;49(6):419. https:\/\/doi.org\/10.1055\/s-0038-1672174.","journal-title":"Neuropediatrics"},{"issue":"6","key":"4373_CR75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/s-0034-1389161","volume":"45","author":"YJ Crow","year":"2014","unstructured":"Crow YJ, Zaki MS, Abdel-Hamid MS, Abdel-Salam G, Boespflug-Tanguy O, Cordeiro NJ, et al. Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. Neuropediatrics. 2014;45(6):386\u201391. https:\/\/doi.org\/10.1055\/s-0034-1389161.","journal-title":"Neuropediatrics"},{"key":"4373_CR76","doi-asserted-by":"publisher","unstructured":"D\u2019Amore A, Tessa A, Casali C, Dotti MT, Filla A, Silvestri G, et al. Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol. 2018;9:2018. https:\/\/doi.org\/10.3389\/fneur.2018.00981.","DOI":"10.3389\/fneur.2018.00981"},{"issue":"11","key":"4373_CR77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jmedgenet-2015-102986","volume":"52","author":"C Freyer","year":"2015","unstructured":"Freyer C, Stranneheim H, Naess K, Mourier A, Felser A, Maffezzini C, et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4\u2013dihydroxybensoic acid. J Med Genet. 2015;52(11):779\u201383. https:\/\/doi.org\/10.1136\/jmedgenet-2015-102986.","journal-title":"J Med Genet"},{"issue":"12","key":"4373_CR78","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/mdc3.14226","volume":"11","author":"L Schierbaum","year":"2024","unstructured":"Schierbaum L, Quiroz V, Tam A, Zubair U, Tochen L, Srouji R, et al. Biallelic variants in COQ4 cause childhood-onset pure hereditary spastic paraplegia. Mov Disord Clin Pract. 2024;11(12):1620\u201324. https:\/\/doi.org\/10.1002\/mdc3.14226.","journal-title":"Mov Disord Clin Pract"},{"key":"4373_CR79","doi-asserted-by":"publisher","unstructured":"Wei Q, Yu H, Wang PS, Xie JJ, Dong HL, Wu ZY, et al. Biallelic variants in the COQ4 gene caused hereditary spastic paraplegia predominant phenotype. CNS Neurosci Ther. 2024;30(4):e14529. https:\/\/doi.org\/10.1111\/cns.14529.","DOI":"10.1111\/cns.14529"},{"issue":"1","key":"4373_CR80","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/mds.29664","volume":"39","author":"X Lin","year":"2024","unstructured":"Lin X, Jiang JY, Hong DJ, Lin KJ, Li JJ, Chen YJ, et al. Biallelic COQ4 variants in hereditary spastic paraplegia: clinical and molecular characterization. Mov Disord. 2024;39(1):152\u201363. https:\/\/doi.org\/10.1002\/mds.29664.","journal-title":"Mov Disord"},{"issue":"8","key":"4373_CR81","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41431-025-01895-w","volume":"33","author":"F Fontaine","year":"2025","unstructured":"Fontaine F, Labalme A, Laurencin C, Theuriet J, Jacquier A, Lacoste N, et al. Homozygous COQ9 mutation: a new cause of potentially treatable hereditary spastic paraplegia. Eur J Hum Genet. 2025;33(8):997\u20131005. https:\/\/doi.org\/10.1038\/s41431-025-01895-w.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"4373_CR82","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/antiox12081652","volume":"12","author":"D Mantle","year":"2023","unstructured":"Mantle D, Millichap L, Castro-Marrero J, Hargreaves IP. Primary coenzyme Q10 deficiency: an update. Antioxidants [Internet]. 2023;12(8):1652. https:\/\/doi.org\/10.3390\/antiox12081652.","journal-title":"Antioxidants"},{"issue":"4","key":"4373_CR83","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ymgme.2019.02.006","volume":"126","author":"D Tonduti","year":"2019","unstructured":"Tonduti D, Izzo G, D\u2019Arrigo S, Riva D, Moroni I, Zorzi G, et al. Spontaneous MRI improvement and absence of cerebral calcification in Aicardi-Gouti\u00e8res syndrome: diagnostic and disease-monitoring implications. Mol Genet Metab. 2019;126(4):489\u201394. https:\/\/doi.org\/10.1016\/j.ymgme.2019.02.006.","journal-title":"Mol Genet Metab"},{"key":"4373_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clineuro.2017.12.018","volume":"165","author":"CC Yang","year":"2018","unstructured":"Yang CC, Wang WC, Yeh TH, Chen TH, Liu YL, Lu MK, et al. A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia: a case report. Clin Neurol Neurosurg. 2018;165:21\u201323. https:\/\/doi.org\/10.1016\/j.clineuro.2017.12.018.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"4373_CR85","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00415-014-7265-3","volume":"261","author":"Z Fan","year":"2014","unstructured":"Fan Z, Greenwood R, Felix ACG, Shiloh-Malawsky Y, Tennison M, Roche M, et al. GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia. J Neurol. 2014;261(3):622\u201324. https:\/\/doi.org\/10.1007\/s00415-014-7265-3.","journal-title":"J Neurol"},{"issue":"6","key":"4373_CR86","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4103\/aian.aian_707_23","volume":"26","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Garg D, Garg A, Srivastava AK. RNASEH2B pathogenic mutation presenting with pure, apparently non-progressive hereditary spastic paraparesis. Ann Indian Acad Neurol. 2023;26(6):1013\u201314. https:\/\/doi.org\/10.4103\/aian.aian_707_23.","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"4373_CR87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.gene.2013.11.043","volume":"536","author":"SM Wakil","year":"2014","unstructured":"Wakil SM, Ramzan K, Abuthuraya R, Hagos S, Al-Dossari H, Al-Omar R, et al. Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C > T. Gene. 2014;536(1):217\u201320. https:\/\/doi.org\/10.1016\/j.gene.2013.11.043.","journal-title":"Gene"},{"issue":"1","key":"4373_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12920-024-01805-x","volume":"17","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Yang Q, Luo J, Zhou X, Yi S, Tan S, et al. Clinical features and molecular genetic investigation of infantile-onset ascending hereditary spastic paralysis (IAHSP) in two Chinese siblings caused by a novel splice site ALS2 variation. BMC Med Genomics. 2024;17(1):44. https:\/\/doi.org\/10.1186\/s12920-024-01805-x.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"4373_CR89","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ajhg.2010.09.013","volume":"87","author":"AH Crosby","year":"2010","unstructured":"Crosby AH, Patel H, Chioza BA, Proukakis C, Gurtz K, Patton MA, et al. Defective mitochondrial mRNA maturation is associated with spastic ataxia. Am J Hum Genet. 2010;87(5):655\u201360. https:\/\/doi.org\/10.1016\/j.ajhg.2010.09.013.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"4373_CR90","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(01)00363-4","volume":"105","author":"C Zhao","year":"2001","unstructured":"Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B\u03b2. Cell. 2001;105(5):587\u201397. https:\/\/doi.org\/10.1016\/S0092-8674(01)00363-4.","journal-title":"Cell"},{"issue":"5","key":"4373_CR91","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Z\u00fcchner","year":"2004","unstructured":"Z\u00fcchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36(5):449\u201351. https:\/\/doi.org\/10.1038\/ng1341.","journal-title":"Nat Genet"},{"issue":"1","key":"4373_CR92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ng0197-62","volume":"15","author":"O Zhuchenko","year":"1997","unstructured":"Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the \u03b11A-voltage-dependent calcium channel. Nat Genet. 1997;15(1):62\u201369. https:\/\/doi.org\/10.1038\/ng0197-62.","journal-title":"Nat Genet"},{"issue":"2","key":"4373_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ng1728","volume":"38","author":"Y Ikeda","year":"2006","unstructured":"Ikeda Y, Dick KA, Weatherspoon MR, Gincel D, Armbrust KR, Dalton JC, et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet. 2006;38(2):184\u201390. https:\/\/doi.org\/10.1038\/ng1728.","journal-title":"Nat Genet"},{"key":"4373_CR94","doi-asserted-by":"publisher","unstructured":"Lise S, Clarkson Y, Perkins E, Kwasniewska A, Sadighi Akha E, Schnekenberg RP, et al. Recessive mutations in SPTBN2 implicate \u03b2-III spectrin in both cognitive and motor development. PLoS Genet. 2012;8(12):e1003074. https:\/\/doi.org\/10.1371\/journal.pgen.1003074.","DOI":"10.1371\/journal.pgen.1003074"},{"issue":"2","key":"4373_CR95","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","volume":"95","author":"PB Agrawal","year":"2014","unstructured":"Agrawal PB, Pierson CR, Joshi M, Liu X, Ravenscroft G, Moghadaszadeh B, et al. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am J Hum Genet. 2014;95(2):218\u201326. https:\/\/doi.org\/10.1016\/j.ajhg.2014.07.004.","journal-title":"Am J Hum Genet"},{"issue":"26","key":"4373_CR96","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1073\/pnas.250289597","volume":"97","author":"T Martinsson","year":"2000","unstructured":"Martinsson T, Oldfors A, Darin N, Berg K, Tajsharghi H, Kyllerman M, et al. Autosomal dominant myopathy: missense mutation (glu-706 \u2192 lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci USA. 2000;97(26):14614\u201319. https:\/\/doi.org\/10.1073\/pnas.250289597.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"4373_CR97","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1093\/brain\/aws205","volume":"135","author":"J Turnbull","year":"2012","unstructured":"Turnbull J, Girard JM, Lohi H, Chan EM, Wang P, Tiberia E, et al. Early-onset Lafora body disease. Brain. 2012;135(9):2684\u201398. https:\/\/doi.org\/10.1093\/brain\/aws205.","journal-title":"Brain"},{"issue":"1","key":"4373_CR98","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13578-022-00916-1","volume":"12","author":"G Ferretti","year":"2022","unstructured":"Ferretti G, Romano A, Sirabella R, Serafini S, Maier TJ, Matrone C. An increase in semaphorin 3A biases the axonal direction and induces an aberrant dendritic arborization in an in vitro model of human neural progenitor differentiation. Cell Biosci. 2022;12(1):182. https:\/\/doi.org\/10.1186\/s13578-022-00916-1.","journal-title":"Cell Biosci"},{"issue":"20","key":"4373_CR99","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1523\/JNEUROSCI.2718-10.2011","volume":"31","author":"H Kabayama","year":"2011","unstructured":"Kabayama H, Takeuchi M, Taniguchi M, Tokushige N, Kozaki S, Mizutani A, et al. Syntaxin 1B suppresses macropinocytosis and semaphorin 3A-induced growth cone collapse. J Neurosci. 2011;31(20):7357\u201364. https:\/\/doi.org\/10.1523\/JNEUROSCI.2718-10.2011.","journal-title":"J Neurosci"},{"issue":"12","key":"4373_CR100","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1523\/JNEUROSCI.22-12-04932.2002","volume":"22","author":"K Mikule","year":"2002","unstructured":"Mikule K, Gatlin JC, de la Houssaye BA, Pfenninger KH. Growth cone collapse induced by semaphorin 3A requires 12\/15-lipoxygenase. J Neurosci. 2002;22(12):4932\u201341. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-12-04932.2002.","journal-title":"J Neurosci"},{"key":"4373_CR101","doi-asserted-by":"publisher","unstructured":"Schlomann U, Schwamborn JC, Muller M, Fassler R, Puschel AW. Correction: the stimulation of dendrite growth by Sema3A requires integrin engagement and focal adhesion kinase ( https:\/\/doi.org\/10.1242\/jcs.038232 ). J Cell Sci. 2020;133(2).","DOI":"10.1242\/jcs.038232"},{"issue":"3","key":"4373_CR102","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/gb-2006-7-3-211","volume":"7","author":"U Yazdani","year":"2006","unstructured":"Yazdani U, Terman JR. The semaphorins. Genome Biol. 2006;7(3):211. https:\/\/doi.org\/10.1186\/gb-2006-7-3-211.","journal-title":"Genome Biol"},{"issue":"4","key":"4373_CR103","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1083\/jcb.200808042","volume":"184","author":"MA Avery","year":"2009","unstructured":"Avery MA, Sheehan AE, Kerr KS, Wang J, Freeman MR. WldS requires Nmnat1 enzymatic activity and N16\u2013VCP interactions to suppress wallerian degeneration. J Cell Biol. 2009;184(4):501\u201313. https:\/\/doi.org\/10.1083\/jcb.200808042.","journal-title":"J Cell Biol"},{"issue":"3","key":"4373_CR104","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/ijms24032049","volume":"24","author":"G Alasiri","year":"2023","unstructured":"Alasiri G. Comprehensive analysis of KCNJ14 potassium channel as a biomarker for cancer progression and development. IJMS. 2023;24(3):2049. https:\/\/doi.org\/10.3390\/ijms24032049.","journal-title":"IJMS"},{"issue":"3","key":"4373_CR105","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s003350010047","volume":"11","author":"C T\u00f6pert","year":"2000","unstructured":"T\u00f6pert C, D\u00f6ring F, Derst C, Daut J, Grzeschik KH, Karschin A. Cloning, structure and assignment to chromosome 19q13 of the human Kir2.4 inwardly rectifying potassium channel gene (KCNJ14). Mamm Genome. 2000;11(3):247\u201349. https:\/\/doi.org\/10.1007\/s003350010047.","journal-title":"Mamm Genome"},{"issue":"11","key":"4373_CR106","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1523\/JNEUROSCI.18-11-04096.1998","volume":"18","author":"C T\u00f6pert","year":"1998","unstructured":"T\u00f6pert C, D\u00f6ring F, Wischmeyer E, Karschin C, Brockhaus J, Ballanyi K, et al. Kir2.4: a novel K+ inward rectifier channel associated with motoneurons of cranial nerve nuclei. J Neurosci. 1998;18(11):4096\u2013105. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-11-04096.1998.","journal-title":"J Neurosci"},{"issue":"14","key":"4373_CR107","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1073\/pnas.0901749106","volume":"106","author":"UI Scholl","year":"2009","unstructured":"Scholl UI, Choi M, Liu T, Ramaekers VT, H\u00e4usler MG, Grimmer J, et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA. 2009;106(14):5842\u201347. https:\/\/doi.org\/10.1073\/pnas.0901749106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4373_CR108","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajhg.2014.12.011","volume":"96","author":"A Masotti","year":"2015","unstructured":"Masotti A, Uva P, Davis-Keppen L, Basel-Vanagaite L, Cohen L, Pisaneschi E, et al. Keppen-lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6. Am J Hum Genet. 2015;96(2):295\u2013300. https:\/\/doi.org\/10.1016\/j.ajhg.2014.12.011.","journal-title":"Am J Hum Genet"},{"issue":"18","key":"4373_CR109","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa032922","volume":"350","author":"AL Gloyn","year":"2004","unstructured":"Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838\u201349. https:\/\/doi.org\/10.1056\/NEJMoa032922.","journal-title":"N Engl J Med"},{"issue":"4","key":"4373_CR110","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/ana.24762","volume":"80","author":"KL Helbig","year":"2016","unstructured":"Helbig KL, Hedrich UBS, Shinde DN, Krey I, Teichmann AC, Hentschel J, et al. A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia. Ann Neurol. 2016;80(4):638\u201342. https:\/\/doi.org\/10.1002\/ana.24762.","journal-title":"Ann Neurol"},{"issue":"14","key":"4373_CR111","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1523\/JNEUROSCI.17-14-05493.1997","volume":"17","author":"LM Bolin","year":"1997","unstructured":"Bolin LM, McNeil T, Lucian LA, DeVaux B, Franz-Bacon K, Gorman DM, et al. HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J Neurosci. 1997;17(14):5493\u2013502. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-14-05493.1997.","journal-title":"J Neurosci"},{"key":"4373_CR112","doi-asserted-by":"publisher","first-page":"544043","DOI":"10.3389\/fcell.2020.544043","volume":"8","author":"S Hauser","year":"2020","unstructured":"Hauser S, Schuster S, Heuten E, H\u00f6flinger P, Admard J, Schelling Y, et al. Comparative transcriptional profiling of motor neuron disorder-associated genes in various human cell culture models. Front Cell Dev Biol. 2020;8:544043. https:\/\/doi.org\/10.3389\/fcell.2020.544043.","journal-title":"Front. Cell Dev. Biol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04373-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:01:52Z","timestamp":1783699312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04373-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4373"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04373-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Social Welfare and Rehabilitation Sciences and the National Institute for Medical Research Development (IR.USWR.REC.1397.55, IR.USWR.REC.1400.053, and IR.NIMAD.REC.1397.299) in Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}